ATE270883T1 - Verwendung von ap-1 aktivatoren zur behandlung von glaukom und erhöhtem augenblutdruck - Google Patents
Verwendung von ap-1 aktivatoren zur behandlung von glaukom und erhöhtem augenblutdruckInfo
- Publication number
- ATE270883T1 ATE270883T1 AT00921979T AT00921979T ATE270883T1 AT E270883 T1 ATE270883 T1 AT E270883T1 AT 00921979 T AT00921979 T AT 00921979T AT 00921979 T AT00921979 T AT 00921979T AT E270883 T1 ATE270883 T1 AT E270883T1
- Authority
- AT
- Austria
- Prior art keywords
- activators
- blood pressure
- treat glaucoma
- eye blood
- elevated eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13013399P | 1999-04-20 | 1999-04-20 | |
PCT/US2000/009503 WO2000062769A2 (en) | 1999-04-20 | 2000-04-07 | Use of ap-1 activators to treat glaucoma and ocular hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE270883T1 true ATE270883T1 (de) | 2004-07-15 |
Family
ID=22443214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00921979T ATE270883T1 (de) | 1999-04-20 | 2000-04-07 | Verwendung von ap-1 aktivatoren zur behandlung von glaukom und erhöhtem augenblutdruck |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1169026B1 (de) |
JP (1) | JP2002542189A (de) |
AT (1) | ATE270883T1 (de) |
AU (1) | AU766199B2 (de) |
BR (1) | BR0009862A (de) |
CA (1) | CA2369126A1 (de) |
DE (1) | DE60012163T2 (de) |
DK (1) | DK1169026T3 (de) |
ES (1) | ES2223502T3 (de) |
HK (1) | HK1039568B (de) |
PT (1) | PT1169026E (de) |
WO (1) | WO2000062769A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010000851A2 (en) * | 2008-07-04 | 2010-01-07 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods for modulating angiogenesis via dystrophin dp71 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
CN1169857A (zh) * | 1996-07-10 | 1998-01-14 | 林东和 | 降眼压活性组合物 |
-
2000
- 2000-04-07 JP JP2000611906A patent/JP2002542189A/ja not_active Withdrawn
- 2000-04-07 AU AU42231/00A patent/AU766199B2/en not_active Ceased
- 2000-04-07 EP EP00921979A patent/EP1169026B1/de not_active Expired - Lifetime
- 2000-04-07 AT AT00921979T patent/ATE270883T1/de not_active IP Right Cessation
- 2000-04-07 CA CA002369126A patent/CA2369126A1/en not_active Abandoned
- 2000-04-07 DK DK00921979T patent/DK1169026T3/da active
- 2000-04-07 DE DE60012163T patent/DE60012163T2/de not_active Expired - Fee Related
- 2000-04-07 WO PCT/US2000/009503 patent/WO2000062769A2/en active IP Right Grant
- 2000-04-07 ES ES00921979T patent/ES2223502T3/es not_active Expired - Lifetime
- 2000-04-07 BR BR0009862-0A patent/BR0009862A/pt not_active Application Discontinuation
- 2000-04-07 PT PT00921979T patent/PT1169026E/pt unknown
-
2002
- 2002-02-15 HK HK02101087.0A patent/HK1039568B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK1169026T3 (da) | 2004-10-04 |
DE60012163D1 (de) | 2004-08-19 |
ES2223502T3 (es) | 2005-03-01 |
AU4223100A (en) | 2000-11-02 |
EP1169026A2 (de) | 2002-01-09 |
WO2000062769A2 (en) | 2000-10-26 |
EP1169026B1 (de) | 2004-07-14 |
CA2369126A1 (en) | 2000-10-26 |
PT1169026E (pt) | 2004-10-29 |
JP2002542189A (ja) | 2002-12-10 |
AU766199B2 (en) | 2003-10-09 |
HK1039568B (zh) | 2004-12-10 |
BR0009862A (pt) | 2002-01-08 |
DE60012163T2 (de) | 2004-11-11 |
WO2000062769A3 (en) | 2001-01-04 |
HK1039568A1 (en) | 2002-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69521620D1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
ATE254461T1 (de) | Behandlung von augenschmerzen | |
DE602004017736D1 (de) | Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust | |
ATE468137T1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
ATE238792T1 (de) | Verwendung von makroliden zur behandlung von glaukom | |
DE60138137D1 (de) | Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen | |
ATE198044T1 (de) | Hydroperoxeicosatetraensäure derivate enthaltende zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges | |
DE60228278D1 (de) | Die verwendung von potenten, selektiven und nontoxischen c-kithemmern zur behandlung von interstitieller blasenentzündung | |
ATE222488T1 (de) | Verwendung von anti-vegf-mitteln zur behandlung der endometriose | |
DE60108857D1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
DE60008143D1 (de) | Lipoxin-a4 und deren analoge zur behandlung von trockenen augen | |
ATE275400T1 (de) | Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ | |
ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
DE60218153D1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
DE60216281D1 (de) | Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen | |
DE69705421D1 (de) | 15-fluoro-prostaglandine als augendrucksenkende mittel | |
ATE258793T1 (de) | 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom | |
DE60135972D1 (de) | Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension | |
ATE270883T1 (de) | Verwendung von ap-1 aktivatoren zur behandlung von glaukom und erhöhtem augenblutdruck | |
DE60213365D1 (de) | Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen | |
MXPA04001255A (es) | Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma. | |
DE60020591D1 (de) | Benzenoidderivate von 15-hydroxyeicosatetraensäure und verfahren zur verwendung zur behandlung des trockenen auges | |
ATE291425T1 (de) | R-eliprodil zur behandlung von glaucoma | |
DE60110449D1 (de) | Verwendung von hydroxyeicosatetraensäure für intraokuläre chirurgie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1169026 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |